$KALV KalVista Pharmaceuticals, Inc. Insider Trading Week 42/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in KalVista Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in KalVista Pharmaceuticals, Inc. in week 42/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 19.02 | 2,544 | 48,389 | 67,969 | 70.5 K to 68 K (-3.61 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.68 | 3,500 | 61,893 | 70,513 | 74 K to 70.5 K (-4.73 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 18.01 | 2,302 | 41,467 | 74,013 | 76.3 K to 74 K (-3.02 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.27 | 5,640 | 97,419 | 76,315 | 82 K to 76.3 K (-6.88 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 18.75 | 5,407 | 101,374 | 78,734 | 84.1 K to 78.7 K (-6.43 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.65 | 3,600 | 63,554 | 84,141 | 87.7 K to 84.1 K (-4.10 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 18.00 | 2,300 | 41,407 | 87,741 | 90 K to 87.7 K (-2.55 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.26 | 5,600 | 96,683 | 90,041 | 95.6 K to 90 K (-5.86 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Sell | S | 19.01 | 3,693 | 70,194 | 195,420 | 199.1 K to 195.4 K (-1.85 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Sell | S | 18.51 | 13,052 | 241,641 | 199,113 | 212.2 K to 199.1 K (-6.15 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Sell | S | 17.48 | 5,800 | 101,412 | 212,165 | 218 K to 212.2 K (-2.66 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Sell | S | 18.01 | 4,776 | 85,992 | 217,965 | 222.7 K to 218 K (-2.14 %) |
| Oct 22 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Sell | S | 17.27 | 11,218 | 193,786 | 222,741 | 234 K to 222.7 K (-4.79 %) |
| Oct 20 2020 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 17.00 | 914 | 15,539 | 81,955 | 82.9 K to 82 K (-1.10 %) |
| Oct 20 2020 | KALV | KalVista Pharmaceu ... | Feener Edward P. | Chief Scientific Of ... | Sell | S | 17.00 | 993 | 16,881 | 95,641 | 96.6 K to 95.6 K (-1.03 %) |
| Oct 20 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Gift | G | 0.00 | 3,000 | 0 | 233,959 | 237 K to 234 K (-1.27 %) |
| Oct 20 2020 | KALV | KalVista Pharmaceu ... | Crockett Thomas Andrew | CEO | Sell | S | 17.01 | 1,261 | 21,444 | 236,959 | 238.2 K to 237 K (-0.53 %) |